专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

41. 发明申请

US20060084687A1 Indole and benzimidazole derivatives 失效
公开(公告)号：US20060084687A1
公开(公告)日：2006-04-20
申请号：US11251440
申请日：2005-10-14
申请人： Rustum Boyce , Hongyan Guo , Kris Mendenhall , Annette Walter , Weibo Wang , Yia Xia
发明人： Rustum Boyce , Hongyan Guo , Kris Mendenhall , Annette Walter , Weibo Wang , Yia Xia
IPC分类号： A61K31/433 , A61K31/427 , A61K31/422 , A61K31/42 , A61K31/4184 , A61K31/416 , C07D417/02 , C07D413/02 , C07D403/02
CPC分类号： C07D403/12 , C07D209/14 , C07D235/14 , C07D401/12 , C07D403/04 , C07D403/14
摘要： The present invention relates to new indole and benzimidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula:

42. 发明授权

US09646336B2 Information processing system and information processing method 有权
公开(公告)号：US09646336B2
公开(公告)日：2017-05-09
申请号：US14197311
申请日：2014-03-05
申请人： Weibo Wang
发明人： Weibo Wang
IPC分类号： G06Q30/06 , G06Q10/08
CPC分类号： G06Q30/0627 , G06Q10/0875
摘要： An information processing system constituted with one or more computers includes a first result storage part to store result values of operation amounts of a first device; a prediction part to generate prediction values of operation amounts of the first device during a period; a calculation part to calculate indicator values based on the prediction values; an extraction part to select a second device that substitutes the first device using the indicator values; a replacement information storage part to store correspondence information between a device before replacement and a device after replacement; an obtainment part to obtain operation amounts of the devices before and after replacement, respectively, assuming that the first device is replaced by the second device; and an output part to output information about the obtained operation amounts.

43. 发明授权

US09229669B2 Device control system, device controller, and device control method 有权
标题翻译：设备控制系统，设备控制器和设备控制方法
公开(公告)号：US09229669B2
公开(公告)日：2016-01-05
申请号：US14644483
申请日：2015-03-11
申请人： Weibo Wang
发明人： Weibo Wang
IPC分类号： G06F15/00 , G06F3/12 , G06K1/00
CPC分类号： G06F3/1236 , G06F3/1203 , G06F3/1221 , G06F3/1229 , G06F3/1285 , G06F3/1287 , G06Q10/06 , Y02D10/1592
摘要： A device control system provided herein includes: a reservation unit that receives inputs of location identification information, a use date/time, and user identification information and makes a reservation so that a user can use a location and a device disposed at the location at the use date/time; a determination unit that acquires user position information and location position information and determines whether or not a predetermined relationship is established between the position of the user and position of the location within a first time period before start of the use date/time; a control information generation unit that acquires device information including at least device identification information for identifying the device on a network and uses the acquired device information to generate control information for controlling operation of the device; and a device control unit that controls operation of the device using the control information when the predetermined relationship is established.
摘要翻译：本文提供的设备控制系统包括：预留单元，其接收位置识别信息的输入，使用日期/时间和用户识别信息，并进行预约，使得用户可以使用位于该位置处的位置和设备处的设备使用日期/时间; 确定单元，其获取用户位置信息和位置位置信息，并且确定在使用日期/时间开始之前的第一时间段内在用户的位置和位置的位置之间是否建立预定关系; 控制信息生成单元，其获取至少包括用于识别网络上的设备的设备识别信息的设备信息，并使用所获取的设备信息来生成用于控制设备的操作的控制信息; 以及设备控制单元，其在建立所述预定关系时使用所述控制信息来控制所述设备的操作。

44. 发明授权

US08648073B2 Certain dipeptidyl peptidase inhibitors 有权
标题翻译：某些二肽基肽酶抑制剂
公开(公告)号：US08648073B2
公开(公告)日：2014-02-11
申请号：US12979571
申请日：2010-12-28
申请人： Weibo Wang , Tongshuang Li
发明人： Weibo Wang , Tongshuang Li
IPC分类号： A61K31/53 , C07D239/20
CPC分类号： C07D401/04
摘要： Provided are certain dipeptidyl peptidase inhibitors, pharmaceutical compositions thereof, and methods of use therefor.
摘要翻译：提供某些二肽基肽酶抑制剂，其药物组合物及其用途的方法。

45. 发明授权

US08370469B2 Management device, management method, and recording medium for synchronizing information from management devices 有权
标题翻译：管理装置，管理方法和用于同步来自管理装置的信息的记录介质
公开(公告)号：US08370469B2
公开(公告)日：2013-02-05
申请号：US12585320
申请日：2009-09-11
申请人： Weibo Wang
发明人： Weibo Wang
IPC分类号： G06F15/16
CPC分类号： H04L29/04 , G03G15/5079 , G03G15/55 , G03G15/553 , G03G2215/00109
摘要： A first acquisition unit acquires an event notification from an MFP and updates first device-status information. A transmission unit transmits the event notification and first reference-destination information. A switching unit switches a first access to the first reference-destination information to a second access to second reference-destination information. A second acquisition unit issues an acquisition request at a first interval, issues an acquisition request at a second interval in response to the event notification, acquires the second device-status information, and update the first device-status information.
摘要翻译：第一采集单元从MFP获取事件通知并更新第一设备状态信息。发送单元发送事件通知和第一参考目的地信息。切换单元将对第一参考目的地信息的第一访问切换到对第二参考目的地信息的第二访问。第二采集单元以第一间隔发出获取请求，响应于事件通知以第二间隔发出获取请求，获取第二设备状态信息，并更新第一设备状态信息。

46. 发明授权

US07932262B2 Quinazolines for PDK1 inhibition 失效
标题翻译：喹唑啉用于PDK1抑制
公开(公告)号：US07932262B2
公开(公告)日：2011-04-26
申请号：US12295967
申请日：2007-04-05
申请人： Savithri Ramurthy , Xiaodong Lin , Sharadha Subramanian , Alice Rico , Xiaojong M. Wang , Rama Jain , Jeremy M. Murray , Stephen E. Basham , Robert L. Warne , Wei Shu , Yasheen Zhou , Jeffrey Dove , Mina Aikawa , Payman Amiri , Weibo Wang , Johanna M. Jansen , Allan S. Wagman , Keith B. Pfister , Simon Ng
发明人： Savithri Ramurthy , Xiaodong Lin , Sharadha Subramanian , Alice Rico , Xiaojong M. Wang , Rama Jain , Jeremy M. Murray , Stephen E. Basham , Robert L. Warne , Wei Shu , Yasheen Zhou , Jeffrey Dove , Mina Aikawa , Payman Amiri , Weibo Wang , Johanna M. Jansen , Allan S. Wagman , Keith B. Pfister , Simon Ng
IPC分类号： A61K31/517
CPC分类号： C07D239/94 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/06 , C07D403/10 , C07D403/12 , C07D403/14 , C07D405/04 , C07D405/12 , C07D405/14 , C07D409/12 , C07D413/04 , C07D413/12 , C07D413/14 , C07D417/04 , C07D417/06 , C07D417/14 , C07D451/06 , C07D453/02
摘要： The invention provides quinazoline compounds that are inhibitors of PDK1. Also provided are pharmaceutical compositions including the compounds, and methods of treating proliferative diseases, such as cancers, with the compounds or compositions.
摘要翻译：本发明提供作为PDK1抑制剂的喹唑啉化合物。还提供了包含该化合物的药物组合物，以及用化合物或组合物治疗增殖性疾病如癌症的方法。

47. 发明授权

US07855295B2 Tetrahydrocarboline compounds as anticancer agents 失效
标题翻译：四氢咔啉化合物作为抗癌剂
公开(公告)号：US07855295B2
公开(公告)日：2010-12-21
申请号：US11042474
申请日：2005-01-24
申请人： Weibo Wang , Zhi-Jie Ni , Paul Barsanti , Sabina Pecchi , Yi Xia , Nathan Brammeier , Megan C. Phillips , Eliza Jazan , Kelly Wayman , David Dibble , Jie-Kai Cheng
发明人： Weibo Wang , Zhi-Jie Ni , Paul Barsanti , Sabina Pecchi , Yi Xia , Nathan Brammeier , Megan C. Phillips , Eliza Jazan , Kelly Wayman , David Dibble , Jie-Kai Cheng
IPC分类号： A61K31/437 , C07D487/04
CPC分类号： C07D471/04
摘要： Tetrahydrocarboline compounds, pharmaceutically acceptable salts, and prodrugs thereof; compositions that include a pharmaceutically acceptable carrier and one or more of the tetrahydrocarboline compounds, either alone or in combination with at least one additional therapeutic agent. Methods of using the tetrahydrocarboline compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases.
摘要翻译：四氢咔啉化合物，其药学上可接受的盐和前药; 包括药学上可接受的载体和一种或多种四氢咔啉化合物的组合物，单独或与至少一种另外的治疗剂组合。单独使用四氢咔啉化合物或与至少一种另外的治疗剂组合使用的方法可用于预防或治疗增殖性疾病。

48. 发明授权

US07820646B2 Cyclized derivatives as Eg-5 inhibitors 失效
标题翻译：环化衍生物作为Eg-5抑制剂
公开(公告)号：US07820646B2
公开(公告)日：2010-10-26
申请号：US11969164
申请日：2008-01-03
申请人： Rustum Boyce , Eric Martin , Weibo Wang , Hong Yang , Paul A. Barsanti
发明人： Rustum Boyce , Eric Martin , Weibo Wang , Hong Yang , Paul A. Barsanti
IPC分类号： C07D403/06 , C07D413/06 , A61K31/422 , A61P35/00
CPC分类号： C07D403/06 , C07D413/06
摘要： The present invention relates to new substituted imidazole compounds have the following Formula (I) and to the pharmaceutically acceptable salts, esters, or prodrugs thereof, to compositions of the compounds together with pharmaceutically acceptable carriers, and to uses of the compounds:
摘要翻译：本发明涉及具有下式（I）的新的取代咪唑化合物及其药学上可接受的盐，酯或前药与化合物与药学上可接受的载体的组合物，以及该化合物的用途：

49. 发明申请

US20100070629A1 Management device, management method, and recording medium 有权
标题翻译：管理装置，管理方法和记录介质
公开(公告)号：US20100070629A1
公开(公告)日：2010-03-18
申请号：US12585320
申请日：2009-09-11
申请人： Weibo Wang
发明人： Weibo Wang
IPC分类号： G06F15/173 , G06F3/12
CPC分类号： H04L29/04 , G03G15/5079 , G03G15/55 , G03G15/553 , G03G2215/00109
摘要： A first acquisition unit acquires an event notification from an MFP and updates first device-status information. A transmission unit transmits the event notification and first reference-destination information. A switching unit switches a first access to the first reference-destination information to a second access to second reference-destination information. A second acquisition unit issues an acquisition request at a first interval, issues an acquisition request at a second interval in response to the event notification, acquires the second device-status information, and update the first device-status information.
摘要翻译：第一采集单元从MFP获取事件通知并更新第一设备状态信息。发送单元发送事件通知和第一参考目的地信息。切换单元将对第一参考目的地信息的第一访问切换到对第二参考目的地信息的第二访问。第二采集单元以第一间隔发出获取请求，响应于事件通知以第二间隔发出获取请求，获取第二设备状态信息，并更新第一设备状态信息。

50. 发明申请

US20100048561A1 QUINAZOLINES FOR PDK1 INHIBITION 失效
标题翻译：用于PDK1抑制剂的喹唑啉
公开(公告)号：US20100048561A1
公开(公告)日：2010-02-25
申请号：US12295967
申请日：2007-04-05
申请人： Savithri Ramurthy , Xiaodong Lin , Sharadha Subramanian , Alice C. Rico , Xiaojing M. Wang , Rama Jain , Jeremy M. Murray , Steven E. Basham , Robert L. Warne , Wei Shu , Yasheen Zhou , Jeffrey Dove , Mina Aikawa , Payman Amiri , Weibo Wang , Johanna M. Jansen , Allan S. Wagman , Keith B. Pfister , Simon Ng
发明人： Savithri Ramurthy , Xiaodong Lin , Sharadha Subramanian , Alice C. Rico , Xiaojing M. Wang , Rama Jain , Jeremy M. Murray , Steven E. Basham , Robert L. Warne , Wei Shu , Yasheen Zhou , Jeffrey Dove , Mina Aikawa , Payman Amiri , Weibo Wang , Johanna M. Jansen , Allan S. Wagman , Keith B. Pfister , Simon Ng
IPC分类号： A61K31/517 , C07D401/12 , C07D401/14 , C07D239/84 , C07D413/14 , A61K31/5377 , A61P35/00
CPC分类号： C07D239/94 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/06 , C07D403/10 , C07D403/12 , C07D403/14 , C07D405/04 , C07D405/12 , C07D405/14 , C07D409/12 , C07D413/04 , C07D413/12 , C07D413/14 , C07D417/04 , C07D417/06 , C07D417/14 , C07D451/06 , C07D453/02
摘要： The invention provides quinazoline compounds that are inhibitors of PDK1. Also provided are pharmaceutical compositions including the compounds, and methods of treating proliferative diseases, such as cancers, with the compounds or compositions.
摘要翻译：本发明提供作为PDK1抑制剂的喹唑啉化合物。还提供了包含该化合物的药物组合物，以及用化合物或组合物治疗增殖性疾病如癌症的方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式